3YK-60841-28719
1 vaccination
1 coded response
4 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 563 / MN
- Registered
- 2021-05-20
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- N/A
Timeline
-
2021-05-20
Registered in v-safe
-
2021-05-20
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-20
Health check-in — day 0, dose 1Feeling: Poor · Fever · Headache, Muscle or body achesAdult check-in
- 2021-05-22
- 2021-05-27
-
2021-11-18
Survey response — 6 months, dose 1MedDRA: Myalgia — Feeling: Poor · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Muscle painMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2021-11-19
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-18 | Successful 2021-11-19 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — 6 months, dose 1
Symptoms: Muscle pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Myalgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release